IRIS
Zambelli, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.909
AS - Asia 3.564
EU - Europa 1.473
SA - Sud America 957
Continente sconosciuto - Info sul continente non disponibili 219
AF - Africa 207
OC - Oceania 21
Totale 11.350
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.709
SG - Singapore 1.921
CN - Cina 758
BR - Brasile 741
IT - Italia 543
VN - Vietnam 431
FI - Finlandia 189
NG - Nigeria 145
IE - Irlanda 136
DE - Germania 125
GB - Regno Unito 120
HK - Hong Kong 110
FR - Francia 97
AR - Argentina 90
CA - Canada 83
IN - India 74
MX - Messico 52
NL - Olanda 48
ID - Indonesia 45
RU - Federazione Russa 40
EC - Ecuador 36
BD - Bangladesh 31
IQ - Iraq 30
SE - Svezia 28
CO - Colombia 24
PL - Polonia 24
CL - Cile 21
ES - Italia 21
ZA - Sudafrica 21
JP - Giappone 20
UA - Ucraina 20
AU - Australia 19
PK - Pakistan 17
PY - Paraguay 17
MA - Marocco 14
CR - Costa Rica 12
UZ - Uzbekistan 12
VE - Venezuela 12
TR - Turchia 11
KZ - Kazakistan 10
CZ - Repubblica Ceca 9
IL - Israele 9
MY - Malesia 9
JM - Giamaica 8
LT - Lituania 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
EE - Estonia 7
EG - Egitto 7
HN - Honduras 7
NO - Norvegia 7
PA - Panama 7
BE - Belgio 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
KE - Kenya 6
OM - Oman 6
RO - Romania 6
TH - Thailandia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AT - Austria 5
BG - Bulgaria 5
BH - Bahrain 5
BO - Bolivia 5
JO - Giordania 5
PE - Perù 5
PH - Filippine 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
CH - Svizzera 4
DZ - Algeria 4
NI - Nicaragua 4
NP - Nepal 4
PT - Portogallo 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
DK - Danimarca 3
GR - Grecia 3
IR - Iran 3
KG - Kirghizistan 3
AM - Armenia 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
KR - Corea 2
MD - Moldavia 2
SY - Repubblica araba siriana 2
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
EU - Europa 1
GY - Guiana 1
Totale 11.120
Salva come PNG Salva come JPEG
Città #
Singapore 792
Ashburn 437
San Jose 375
The Dalles 314
Shanghai 244
New York 240
Chandler 219
Beijing 199
Milan 190
Helsinki 189
Council Bluffs 177
Ho Chi Minh City 169
Benin City 143
Dallas 143
Dublin 135
Princeton 123
Lawrence 113
Santa Clara 113
Los Angeles 110
Hong Kong 100
Hanoi 92
Wilmington 83
Rome 75
Boardman 65
São Paulo 62
Paris 59
Phoenix 53
London 44
Buffalo 38
Amsterdam 37
Rio de Janeiro 30
San Mateo 29
Philadelphia 28
Chicago 27
Brooklyn 23
Seattle 23
Charlotte 22
Figino 21
Warsaw 21
Florence 20
Mexico City 20
Montreal 20
Atlanta 19
Brasília 18
Naples 18
Da Nang 17
Turin 17
Ann Arbor 16
Belo Horizonte 16
Mumbai 16
Fairfield 15
Haiphong 15
Houston 15
Brownsville 14
Chennai 14
Toronto 14
Boston 13
Denver 13
Guayaquil 13
Leawood 13
Bologna 12
Johannesburg 12
Quito 12
Salvador 12
San Antonio 12
San Francisco 12
Tokyo 12
Cincinnati 11
Fortaleza 11
Miami 11
Richmond 11
Tashkent 11
Thái Bình 11
Buenos Aires 10
Falkenstein 10
Frankfurt am Main 10
Las Vegas 10
Montgomery Village 10
Porto Alegre 10
Queens 10
San José 10
Asunción 9
Baghdad 9
Curitiba 9
Milwaukee 9
Munich 9
Newark 9
North Bergen 9
Orem 9
Pasadena 9
Poplar 9
San Diego 9
The Bronx 9
Venice 9
Woodbridge 9
Assago 8
Biên Hòa 8
Detroit 8
Norwalk 8
Oxnard 8
Totale 6.089
Salva come PNG Salva come JPEG
Nome #
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants 142
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 127
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signature 123
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 109
34. Trabectedin and indole-3-carbinol combination in heavily pretreated metastatic breast cancer: Results of a pilot clinical study 109
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 109
Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19 105
ACUTE UPPER GASTROINTESTINAL BLEEDING (AUGB) IN ITALY: AN INTERIM ANALYSIS OF THE ORGANIZATIONAL ASPECTS CARING AN EVOLVING DISEASE 102
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 99
Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen - A pilot study in patients with refractory malignancies 99
Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues. 96
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 95
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial 95
Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling 94
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter? 91
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer 90
Clinical toxicity of cryopreserved circulating progenitor cells infusion 90
Cellular and molecular determinants of all‐ trans retinoic acid sensitivity in breast cancer: Luminal phenotype and α expression 89
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score 89
Adding pertuzumab to adjuvant therapy for high-risk HER2-positive early breast cancer in APHINITY: a GRADE analysis 89
A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progression 89
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 88
Clinical Review on the Management of Breast Cancer Visceral Crisis 85
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study 85
Pulmonary function and complications following chemotherapy and stem cell support in breast cancer 84
Analysis of SEMA6B gene expression in breast cancer: Identification of a new isoform 84
Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC) 83
Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer 83
Prospective multicenter quality assessment of endotherapy of biliary stones: does center volume matter? 83
Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients 82
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe 82
Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy 82
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective 81
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 80
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations 78
Opportunities and Challenges of Synthetic Data Generation in Oncology 78
PREDICTIVE FACTORS OF MORTALITY IN ACUTE GASTROINTESTINAL BLEEDING IN ITALY (AUGIB): A NEW PRE-ENDOSCOPY PROGNOSTIC MODEL FROM A MULTICENTER STUDY 78
TRANSFUSION STRATEGY AND DEATH RISK IN PATIENTS WITH ACUTE NON-VARICEAL UPPER GASTRO INTESTINAL BLEEDING (NV-UGIB) IN ITALY: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY 78
Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy 78
Bone-Active Drugs in Pre-Menopausal Women with Breast Cancer Under Hormone Deprivation Therapies 77
A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971 77
STEM-CELL FACTOR AND INTERLEUKIN-6, ALONE OR IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, DO NOT AFFECT THE GROWTH OF SOLID TUMOR-CELL LINES 77
Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients 77
Targeting triple negative breast cancer: Is p53 the answer? 77
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry 76
Circulating CD33+large mononuclear cells contain three distinct populations with phenotype of putative antigen-presenting cells including myeloid dendritic cells and CD14+monocytes with their CD16+subset 76
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study 76
Cellular and molecular determinants of breast cancer sensitivity to all-trans retinoic acid: Identification of a gene expression fingerprint predicting responsiveness 76
Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors 76
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 74
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies 74
Poor outcome of patients with resectable breast cancer receiving adjuvant high-dose sequential chemotherapy following preoperative treatment 74
Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy 74
A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer 74
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer 74
An ICT infrastructure to integrate clinical and molecular data in oncology research 74
Absence of the K303R estrogen receptor alpha mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment 73
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 73
From cancer patients to cancer survivors: the issue of Cardioncology--a biological perspective. 72
Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874) 71
trattamento conservativo dell' osteonecrosi spontaea del ginocchio in fase iniziale con campi pulsati: studio a 2 anni di follow-up minimo 71
Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer 71
Trabectedin for the treatment of breast cancer 71
Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study 71
Short commentaries on data published by Petit et al. on locoregional risk after lipofilling in breast cancer patients 71
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 70
Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study 70
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer 70
Multi-institutional retrospective analysis of clinical and pathological factors predicting resistance to lapatinib-based therapy in HER2 positive metastatic breast cancer (HER2+ MBC) 70
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer 69
Epithelial tumour cell detection and the unsolved problems of nested RT-PCR: A new sensitive one step method without false positive results 69
Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy 69
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 69
Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis 69
OUTPATIENT MANAGEMENT OF PATIENTS WITH GLASGOW-BLATCHFORD BLEEDING SCORE LOW-RISK UPPER-GASTROINTESTINAL HEMORRHAGE: A MULTICENTER VALIDATION STUDY IN ITALY 68
T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8(+) subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence 68
No correlation between plasma D-dimer levels and lymph node involvement in operable breast cancer 68
ONCO-i2b2: Improve Patients Selection through Case-Based Information Retrieval TechniquesData Integration in the Life Sciences 68
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds 67
An epirubicin/paclitaxel combination mobilizes large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen 67
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) 67
Retinoids and breast cancer: from basic studies to the clinic and back again 67
The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question 66
Common Misconceptions about Diet and Breast Cancer: An Unclear Issue to Dispel 66
AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128 66
Evolving phenotypes of non-hospitalized patients that indicate long COVID 66
SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY 66
What Every Reader Should Know About Studies Using Electronic Health Record Data but May Be Afraid to Ask 65
Remodelling of the Ca2+ signalling machinery in endothelial progenitor cells isolated from breast cancer patients 65
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems 65
Commentary: Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel 65
Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives 64
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 64
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow 64
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets 63
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study 63
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer 63
MORTALITY IN UPPER GASTROINTESTINAL BLEEDING IN ITALY: DATA FROM NATIONAL SURVEY 62
Free mobility of medical oncologists across the European Union: still a false myth 62
Long term survival of HER2-positive early breast cancer treated with trastuzumab-based adjuvant regimen: a large cohort study from clinical practice 62
Totale 7.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.097
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022465 0 0 0 17 5 6 7 12 183 80 136 19
2022/20231.057 248 48 135 86 98 62 5 53 100 140 67 15
2023/20241.012 71 80 157 47 36 197 54 46 27 31 100 166
2024/20251.583 43 7 12 20 23 273 104 85 218 418 172 208
2025/20265.311 655 290 374 740 243 154 1.011 242 327 366 272 637
2026/20271.777 553 280 714 230 0 0 0 0 0 0 0 0
Totale 11.350